Related Experiment Video
Updated: Aug 12, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated
Abstract:
Osteosarcomas are immune-resistant and metastatic as a result of elevated nonsense-mediated RNA decay (NMD), reactive oxygen species (ROS), and epithelial-to-mesenchymal transition (EMT). Although vitamin D has anti-cancer effects, its effectiveness and mechanism of action against osteosarcomas are poorly understood. In this study, we assessed the impact of vitamin D and its receptor (VDR) on the NMD-ROS-EMT signaling axis in in vitro and in vivo osteosarcoma animal models. Initiation of VDR signaling facilitated the enrichment of EMT pathway genes, after which 1,25(OH) 2 D, the active vitamin D derivative, inhibited the EMT pathway in osteosarcoma subtypes. The ligand-bound VDR directly downregulated the EMT inducer SNAI2 , differentiating highly metastatic from low metastatic subtypes and 1,25(OH) 2 D sensitivity. Moreover, epigenome-wide motif and putative target gene analysis revealed the VDR’s integration with NMD tumorigenic and immunogenic pathways. In an autoregulatory manner, 1,25(OH) 2 D inhibited NMD machinery genes and upregulated NMD target genes implicated in anti-oncogenic activity, immunorecognition, and cell-to-cell adhesion. Dicer substrate siRNA knockdown of SNAI2 revealed superoxide dismutase 2 (SOD2)-mediated antioxidative responses and 1,25(OH) 2 D sensitization via non-canonical SOD2 nuclear-to-mitochondrial translocalization leading to overall ROS suppression. In a mouse xenograft metastasis model, the therapeutically relevant vitamin D derivative calcipotriol inhibited osteosarcoma metastasis and tumor growth shown for the first time. Our results uncover novel osteosarcoma-inhibiting mechanisms for vitamin D and calcipotriol that may be translated to human patients.
Insights
Vitamin D inhibits osteosarcoma metastasis by targeting nonsense-mediated RNA decay (NMD), reactive oxygen species (ROS), and epithelial-to-mesenchymal transition (EMT). The active form, 1,25(OH)2D, and calcipotriol suppress tumor growth and metastasis.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Osteosarcomas are aggressive, metastatic cancers resistant to immune responses.
- Elevated nonsense-mediated RNA decay (NMD), reactive oxygen species (ROS), and epithelial-to-mesenchymal transition (EMT) contribute to osteosarcoma's malignancy.
- The anti-cancer potential of vitamin D in osteosarcoma remains largely uncharacterized.
Approach:
- Investigated the impact of vitamin D and its receptor (VDR) on the NMD-ROS-EMT axis in vitro and in vivo.
- Utilized 1,25(OH)2D, the active vitamin D metabolite, and epigenome-wide analysis.
- Employed mouse xenograft metastasis models and siRNA knockdown of SNAI2.
Key Points:
- VDR signaling initially promotes EMT genes, but 1,25(OH)2D subsequently inhibits EMT by downregulating SNAI2.
- VDR integrates with NMD pathways, autoregulating NMD machinery and upregulating anti-oncogenic NMD targets.
- Vitamin D enhances antioxidative responses via SOD2 and suppresses ROS, sensitizing cells to its effects.
Conclusions:
- Vitamin D and its derivative calcipotriol exhibit potent anti-osteosarcoma effects, inhibiting metastasis and tumor growth.
- Novel mechanisms involving NMD, ROS, and EMT pathways elucidate vitamin D's anti-cancer action.
- Findings suggest therapeutic potential for vitamin D derivatives in treating osteosarcoma patients.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Osteoclasts in Bone Remodeling

